The role of ADP‐ribosylation and GM1‐binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat‐labile enterotoxin and Vibrio cholerae cholera toxin

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Immunology and Cell Biology

• Publication date

  1998-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1440-1711.1998.00745.xPMID 9682971
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral tolerance.

  2000cited by this paper
• Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat‐labile enterotoxin

  1999cited by this paper
• Mutational analysis of the role of ADP‐ribosylation activity and GM1 ‐binding activity in the adjuvant properties of the Escherichia coli heat‐labile enterotoxin towards intranasally administered keyhole limpet hemocyanin

  1998cited by this paper
• Musosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: Induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen

  1998cited by this paper
• Non-toxic variants of the Escherichia coli heat-labile enterotoxin as mucosal immunogens and adjuvants

  1998cited by this paper
• Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat‐labile enterotoxin and its B subunit

  1998cited by this paper
• Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina

  1997cited by this paper
• Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system

  1997cited by this paper
• A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.

  1997cited by this paper
• Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin

  1997cited by this paper
• Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection

  1997cited by this paper
• Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women

  1997cited by this paper
• Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin

  1997cited by this paper
• Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine.

  1997cited by this paper
• Oral but Not Parenteral Interleukin (IL)-12 Redirects T Helper 2 (Th2)-type Responses to an Oral Vaccine Without Altering Mucosal IgA Responses

  1997cited by this paper
• Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection

  1997cited by this paper
• Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit.

  1997cited by this paper
• Mutants in the ADP-ribosyltransferase Cleft of Cholera Toxin Lack Diarrheagenicity but Retain Adjuvanticity

  1997cited by this paper
• Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit.

  1996cited by this paper
• Antigen sampling across epithelial barriers and induction of mucosal immune responses.

  1996cited by this paper
• Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin

  1996cited by this paper
• Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses

  1996cited by this paper
• Antibody responses and protection in mice immunized orally against influenza virus.

  1996cited by this paper
• Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets.

  1996cited by this paper
• Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit

  1996cited by this paper
• Development

  1996cited by this paper
• Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.

  1996cited by this paper
• Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

  1996cited by this paper
• Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant

  1996cited by this paper
• Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection

  1996cited by this paper
• Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.

  1995cited by this paper
• Role of a potential endoplasmic reticulum retention sequence (RDEL) and the Golgi complex in the cytotonic activity of Escherichia coli heat‐labile enterotoxin

  1995cited by this paper
• Targeting of cholera toxin and Escherichia coli heat labile toxin in polarized epithelia: role of COOH-terminal KDEL

  1995cited by this paper
• Impaired mucosal immune responses in interleukin 4-targeted mice.

  1995cited by this paper
• Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus.

  1995cited by this paper
• The 2.4 A crystal structure of cholera toxin B subunit pentamer: choleragenoid.

  1995cited by this paper
• Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates.

  1995cited by this paper
• Intranasal immunization with liposomes induces strong mucosal immune responses in mice

  1995cited by this paper
• Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis

  1995cited by this paper
• The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins.

  1995cited by this paper
• Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

  1995cited by this paper
• AB5 toxins.

  1995cited by this paper
• Monomer of the B Subunit of Heat‐Labile Enterotoxin from Enterotoxigenic Escherichia coli Has Little Ability to Bind to GM1 Ganglioside Compared to Its Coligenoid

  1995cited by this paper
• Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit

  1995cited by this paper
• Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.

  1995cited by this paper
• The three-dimensional crystal structure of cholera toxin.

  1995cited by this paper
• Oral tolerance.

  1994cited by this paper
• Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine.

  1994cited by this paper
• Immunological memory after immunization with oral cholera B subunit--whole-cell vaccine in Swedish volunteers.

  1994cited by this paper
• Handbook of mucosal immunology

  1994cited by this paper
• Comparison of the glycolipid-binding specificities of cholera toxin and porcineEscherichia coli heat-labile enterotoxin: identification of a receptor-active non-ganglioside glycolipid for the heat-labile toxin in infant rabbit small intestine

  1994cited by this paper
• A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit

  1994cited by this paper
• Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine.

  1994cited by this paper
• Crystal structure of cholera toxin B‐pentamer bound to receptor GM1 pentasaccharide

  1994cited by this paper
• Enhancement of anti-Shigella lipopolysaccharide (LPS) response by addition of the cholera toxin B subunit to oral and intranasal proteosome-Shigella flexneri 2a LPS vaccines

  1994cited by this paper
• Successful immunization against gastric infection with Helicobacter species: use of a cholera toxin B-subunit-whole-cell vaccine

  1994cited by this paper
• Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin.

  1994cited by this paper
• Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant

  1993cited by this paper
• Intranasal immunization against herpes simplex virus infection by using a recombinant glycoprotein D fused with immunomodulating proteins, the B subunit of Escherichia coli heat-labile enterotoxin and interleukin-2.

  1993cited by this paper
• Effect of cholera toxin on vaccine-induced immunity and infection in murine schistosomiasis mansoni

  1993cited by this paper
• Cholera toxin adjuvant greatly promotes antigen priming of T cells

  1993cited by this paper
• Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant.

  1993cited by this paper
• Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues

  1993cited by this paper
• Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems.

  1993cited by this paper
• Oral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57BL/6 mice

  1993cited by this paper
• Mucosal immunization with a subunit respiratory syncytial virus vaccine in mice.

  1993cited by this paper
• Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit

  1993cited by this paper
• Killed Campylobacter elicits immune response and protection when administered with an oral adjuvant.

  1993cited by this paper
• The mucosal immune system: from fundamental concepts to vaccine development.

  1992cited by this paper
• The adjuvant effect of Vibrio cholerae and Escherichia coli heat‐labile enterotoxins is linked to their ADP‐ribosyltransferase activity

  1992cited by this paper
• The role of nasopharyngeal lymphoid tissue.

  1992cited by this paper
• Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin.

  1992cited by this paper
• Oral immunization with bacterial polysaccharide and adjuvant enhances antigen-specific pulmonary secretory antibody response and resistance to pneumonia.

  1991cited by this paper
• Mucosal priming of T-lymphocyte responses to fed protein antigens using cholera toxin as an adjuvant.

  1991cited by this paper
• Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans

  1991cited by this paper
• Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli

  1991cited by this paper
• Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: Disproportionate cholera toxin enhancement of the IgA B cell response

  1990cited by this paper
• Whole Cholera Toxin and B Subunit Act Synergistically as an Adjuvant for the Mucosal Immune Response of Mice to Keyhole Limpet Haemocyanin

  1990cited by this paper
• Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin

  1989cited by this paper
• Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues

  1989cited by this paper
• Intraduodenal application of cholera holotoxin increases the potential of clones from Peyer's patch B cells of relevant and unrelated specificities to secrete IgG and IgA.

  1988cited by this paper
• Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-IIb

  1988cited by this paper
• Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques

  1988cited by this paper
• Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit.

  1988cited by this paper
• Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding

  1988cited by this paper
• Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.

  1988cited by this paper
• Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

  1988cited by this paper
• Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response.

  1987cited by this paper
• Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.

  1986cited by this paper
• Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.

  1984cited by this paper
• Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen.

  1984cited by this paper
• Evolution and structure of two ADP‐ribosylation enterotoxins, Escherichia coli heat‐labile toxin and cholera toxin

  1984cited by this paper
• Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin

  1982cited by this paper
• Determinants of the localization, magnitude, and duration of a specific mucosal IgA plasma cell response in enterically immunized rats.

  1982cited by this paper
• Evidence for a common mucosal immunologic system. II. Influence of the estrous cycle on B immunoblast migration into genital and intestinal tissues.

  1980cited by this paper
• Antigenic Specificity of Neutralizing Antibody to Cholera Toxin

  1979cited by this paper
• Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues.

  1979cited by this paper

• Plasmid vector(s) in Bacillus thuringiensis harbor genes for insect pest control and for neglected infectious diseases in humans

  2024cites this paper
• Recombinant lactic acid bacteria as promising vectors for mucosal vaccination

  2021cites this paper
• Production of a Candidate Recombinant Protein Vaccine for Mannheimia haemolytica in Lettuce and Tobacco Chloroplasts

  2018cites this paper
• Adjuvant formulations for virus-like particle (VLP) based vaccines.

  2017cites this paper
• Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein

  2017cites this paper
• The B subunit of Escherichia coli heat-labile toxin alters the development and antigen-presenting capacity of dendritic cells

  2015cites this paper
• Parenteral Adjuvant Effects of an Enterotoxigenic Escherichia coli Natural Heat-Labile Toxin Variant

  2014cites this paper
• Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.

  2013cites this paper
• This information is current as and Ig-Binding Activity Dependent on the ADP-Ribosyltransferase Gene Fusion Protein, CTA1-DD, Is Critically Adjuvanticity of the Cholera Toxin A1-Based

  2013cites this paper
• Evaluation of Recombinant Forms of the Shiga Toxin Variant Stx2eB Subunit and Non-Toxic Mutant Stx2e as Vaccine Candidates against Porcine Edema Disease

  2013cites this paper
• RENATURAÇÃO DE PROTEÍNAS COM ESTRUTURA QUATERNÁRIA

  2012cites this paper
• Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide.

  2011cites this paper
• Expression And Functional Evaluation Of Exendin 4 Fused To Cholera Toxin B Subunit In Tobacco Chloroplast To Treat Type 2 Diabetes

  2011cites this paper
• Functional Pentameric Formation via Coexpression of the Escherichia coli Heat-Labile Enterotoxin B Subunit and Its Fusion Protein Subunit with a Neutralizing Epitope of ApxIIA Exotoxin Improves the Mucosal Immunogenicity and Protection against Challenge by Actinobacillus pleuropneumoniae

  2011cites this paper
• Low Cost Production Of Proinsulin In Tobacco And Lettuce Chloroplasts For Injectable Or Oral Delivery Of Functional Insulin And

  2010cites this paper
• Bacterial toxins and their carbohydrate receptors at the host–pathogen interface

  2010cites this paper
• Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery.

  2010cites this paper
• Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice

  2010influential citation
• Functional Diversity of Heat-labile Toxins (LT) Produced by Enterotoxigenic Escherichia coli

  2010cites this paper
• Molecular basis of cholera blood‐group dependence and implications for a world characterized by climate change

  2010cites this paper
• Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site.

  2009cites this paper
• Expression of functional pentameric heat-labile enterotoxin B subunit of Escherichia coli in Saccharomyces cerevisiae.

  2009cites this paper
• Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum)

  2008cites this paper
• Sub-Nucleocapsid Nanoparticles: A Nasal Vaccine against Respiratory Syncytial Virus

  2008cites this paper
• Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by Type I and Type II heat-labile enterotoxins

  2007cites this paper
• Analysis of the cellular immune response induced by Bacillus thuringiensis Cry1A toxins in mice: effect of the hydrophobic motif from diphtheria toxin.

  2007cites this paper
• Heat-Labile Enterotoxins

  2006cites this paper
• Mucosal Adjuvant Properties of the Shigella Invasin Complex

  2006cites this paper
• Induction and recall of immune memory by mucosal immunization with a non‐toxic recombinant enterotoxin‐based chimeric protein

  2005cites this paper
• From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1‐DD/ISCOM

  2004cites this paper
• Expression of the B subunit of the heat-labile enterotoxin of Escherichia coli in tobacco mosaic virus-infected Nicotiana benthamiana plants and its characterization as mucosal immunogen and adjuvant.

  2004cites this paper
• Studies on the immunogenic potential of plant-expressed cholera toxin B subunit

  2004cites this paper
• Structural implication of the induced immune response by Bacillus thuringiensis Cry proteins: role of the N-terminal region.

  2004cites this paper
• Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis.

  2003cites this paper
• Expression of Cholera Toxin B Subunit in Transgenic Tomato Plants

  2002cites this paper
• Oxidised mannan as a novel adjuvant inducing mucosal IgA production.

  2002cites this paper
• New insights into the structure-function relationships and therapeutic applications of cholera-like enterotoxins.

  2002cites this paper
• Contribution of the ADP-ribosylating and receptor-binding properties of cholera-like enterotoxins in modulating cytokine secretion by human intestinal epithelial cells.

  2002cites this paper
• Epidermal powder immunization using non-toxic bacterial enterotoxin adjuvants with influenza vaccine augments protective immunity.

  2002cites this paper
• The B-cell targeted CTA1-DD vaccine adjuvant is highly effective at enhancing antibody as well as CTL responses.

  2001cites this paper
• The ADP-Ribosylating CTA1-DD Adjuvant Enhances T Cell-Dependent and Independent Responses by Direct Action on B Cells Involving Anti-Apoptotic Bcl-2- and Germinal Center-Promoting Effects1

  2000cites this paper
• Cholera toxin and related enterotoxins: a cell biological and immunological perspective.

  2000cites this paper
• Germinal Center-Promoting Effects Involving Anti-Apoptotic Bcl-2-and Responses by Direct Action on B Cells IndependentEnhances T Cell-Dependent and The ADP-Ribosylating CTA 1-DD Adjuvant

  2000cites this paper
• Enhancement of common mucosal immunity in aged mice following their supplementation with various antioxidants.

  2000cites this paper
• Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat‐labile enterotoxin

  1999cites this paper
• The therapeutic potential of plant-derived vaccines and antibodies.

  1999cites this paper
• Ig-Binding Activity Dependent on the ADP-Ribosyltransferase Gene Fusion Protein , CTA 1-DD , Is Critically Adjuvanticity of the Cholera Toxin A 1-Based Nedrud

  1999cites this paper